Report Overview

Global Wearable Injectors Market- Industry Trends & Forecast Report 2027

The global wearable injectors market was worth USD 6.6 billion in 2020 and is further projected to reach USD 12.6 billion by the year 2027, growing at a CAGR of 9.8% in the forecast period. The demand for wearable injectors is growing at a high rate because of the increasing prevalence of cardiovascular and other chronic diseases among all age groups across the globe. Furthermore, increasing healthcare expenditure and public and private investment towards healthcare infrastructural development is anticipated to boost the global wearable injectors market in the forecast period.

Source: BlueWeave Consulting

Global Wearable Injectors Market- Overview

Wearable injectors are drug delivery devices used for delivering larger volumes of drugs (usually more than 2 ml). These devices control the volume and viscosity of drugs and allow high concentrated drugs to be diluted into larger volumes for longer periods. Wearable injectors prove very convenient for patients who require a drug supply over a long period. These devices are generally used for out-patients as an alternative for hospital admittance since they can easily be used in non-clinical settings.

Global Wearable Injectors Market Forecast and Trends

Growth Drivers

Increasing Prevalence of Chronic Diseases

The demand for wearable injectors is soaring worldwide due to the growing prevalence of chronic and lifestyle-associated diseases. The prevalence of chronic diseases, such as heart disease, cancer, stroke, and diabetes, is increasing due to the alteration in lifestyle and lack of access to preventive care. As reported by the WHO, around 523 million people suffer from cardiovascular disease and around 422 million people suffer from diabetes globally and these numbers are rising at a high rate, especially in low and middle-income countries.

Technological Advancements in Wearable Injectors

In light of the increasing demand for medical devices that are easy to use, medical device manufacturers and research institutes are dedicating considerable resources to bringing technological advancements into their products. For instance, researchers from the National University of Singapore have developed a way to transmit power from the human body to wearable devices that face the issue of battery discharge, such as wearable injectors, ECG monitor patches, etc. Such developments are estimated to boost the wearable injectors market demand during the forecast period.

Restraints

High Cost of Wearable Injectors

Wearable injectors are relatively expensive compared to other delivery options, such as oral medication. As a result, the adoption of wearable injectors is being hampered by their high cost. It is recommended that pharmaceutical companies minimize the cost of these medical technologies to promote their widespread adoption. Furthermore, the lack of reimbursement policies, especially in developing and underdeveloped countries, also limits its adoption among patients. This acts as a major restraining factor for the global wearable injectors market growth.

Impact of COVID-19 on Global Wearable Injectors Market

The sudden outbreak of the COVID-19 pandemic provided lucrative growth opportunities to the global wearable injectors market. Healthcare facilities were burdened by the increasing COVID-19 cases due to limited resources. Due to this, the governments of various countries imposed nationwide lockdowns that restricted the hospital visits of chronic patients. This resulted in an increase in demand for wearable injectors as patients with chronic conditions, such as cancer or diabetes required regular delivery of drugs even during their quarantine period.

Global Wearable Injectors Market - By Type

Based on types, the global wearable injectors market is segmented into body-worn patch injectors, off-body worn belt injectors, and bolus injectors. Body-worn patch injectors account for the largest share of the market as they can be easily worn and used in nonclinical settings due to their convenience and easy wearability. These types of wearable injectors offer ease of drug delivery in regulated amounts for a prolonged period. However, the off-body worn belt injector is projected to register the highest CAGR during the forecast period.

Global Wearable Injectors Market - By Technology

Based on technologies, the global wearable injectors market is segmented into the electronic injector, mechanical injector, and others. Among these, the electronic injector segment accounts for the largest market share. This technology offers high efficacy and safety to amateur users in home-care settings. Furthermore, the chances of errors in electronic injectors are also low, due to which its demand is very prominent in the market. However, the mechanical injector is anticipated to witness a high growth rate during the forecast period.

Global Wearable Injectors Market - Regional Insights

Geographically, the global wearable injectors market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle-East & Africa. North America dominates the market among all the regions because of the rising prevalence of chronic disease and high medical expenditure in this region. Furthermore, the high concentration of leading wearable injector players, along with better accessibility to advanced medical technologies, play a crucial factor in propelling the market’s growth. Nevertheless, due to the rapid expansion of healthcare in Asia-Pacific, the region is expected to report the highest CAGR during the forecast period.

Competitive Landscape

The leading players in the global wearable injectors market are Amgen Inc., Ypsomed, Becton, Dickinson and Company, Tandem Diabetes Care, Inc., Dexcom, Inc., Sensile Medical, Enable Injections, Insulet Corporation, Medtronic plc, Johnson & Johnson, F. Hoffmann-La Roche Ltd., Neuma, Weibel CDS AG, Sorrel Medical, Stevanato Group, Sonceboz, Elcam Drug Delivery Devices, West Pharmaceutical Services, Inc., Sensile Medical, and other prominent players.

Consumers prefer to put their trust in established medical device companies, such as Johnson & Johnson, Becton, Dickinson & Company, etc. However, the market is welcoming new players providing better technology. Further, companies often use market strategies like partnerships, mergers, acquisitions, joint ventures, etc., to gain a competitive edge.

Recent Development

• In February 2021, Phillips-Medisize announced its collaboration with Subject, a medical devices company, to introduce a wearable bolus injector, which is a low-cost, patient-friendly, prefilled wearable injector for single-use.

Scope of the Report

By Type

• Body-Worn Patch Injectors
• Off-Body Worn Belt Injector
• Bolus Injector

By Technology

• Electronic Injector
• Mechanical Injector
• Others

By Application

• Cancer
• Infectious Disease
• Autoimmune Disease
• Cardiovascular Disease
• Blood Disorder
• Others

By End-User

• Hospital
• Lab And Diagnostics
• Homecare
• Others

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

1. Research Framework
   1. Research Objective
   2. Product Overview
   3. Key Market Segments
2. Research Methodology
   1. Qualitative Research
   2. Methodology
   3. Regional Split of Primary & Secondary Research
   4. Secondary Research
   5. Primary Research
      1. Breakdown of Primary Research Respondents, By Region
      2. Breakdown of Primary Research Respondents, By Industry Participants
   6. Market Technology Estimation
   7. Assumptions for the Study
   8. Market Breakdown & Data Triangulation
3. Executive Summary
4. Industry Insight and Growth Strategy
   1. Value Chain Analysis
   2. DROC Analysis
      1. Market Drivers
         1. Increasing Prevalence Of Chronic Diseases
         2. Favorable Reimbursement Policies In Developed Countries
      2. Market Restraints
         1. High Cost Of Wearable Injectors
      3. Market Challenges
         1. Limited Reimbursement Policies Emerging Economies
      4. Market Opportunity
         1. Extensive Research And Development Activities
         2. Positive Impact of the COVID-19 Pandemic
   3. Recent Developments
   4. Porter’s Five Forces Analysis
      1. Bargaining Power of Buyers
      2. Bargaining Power of Suppliers
      3. Intensity of Rivalry
      4. Threat of New Entrants
      5. Threat of Substitutes
5. Global Wearable Injectors Market Overview
   1. Market Technology & Forecast by Value, 2017-2027
   2. Market Technology and Forecast, By Segment
      1. By Type
         1. Body-Worn Patch Injectors
         2. Off-Body Worn Belt Injector
         3. Bolus Injector
      2. By Technology
         1. Electronic Injector
         2. Mechanical Injector
         3. Others
      3. By Application
         1. Cancer
         2. Infectious Disease
         3. Autoimmune Disease
         4. Cardiovascular Disease
         5. Blood Disorder
         6. Others
      4. By End-User
         1. Hospital
         2. Lab And Diagnostics
         3. Homecare
         4. Others
      5. By Region
         1. North America
         2. Europe
         3. Asia-Pacific
         4. Latin America
         5. Middle East & Africa
6. North America Wearable Injectors Market Overview
   1. Market Technology and Forecast
      1. By Value (USD Billion), 2020-2027
   2. Market Share and Forecast
      1. By Type
      2. By Technology
      3. By Application
      4. By End-User
      5. By Country
         1. U.S.
         2. Canada
7. Europe Wearable Injectors Market Overview
   1. Market Technology and Forecast
      1. By Value (USD Billion), 2020-2027
   2. Market Share and Forecast
      1. By Type
      2. By Technology
      3. By Application
      4. By End-User
      5. By Country
         1. Germany
         2. U.K.
         3. Russia
         4. France
         5. Italy
         6. Spain
         7. Rest of Europe
8. APAC Wearable Injectors Market Overview
   1. Market Technology and Forecast
      1. By Value (USD Billion), 2020-2027
   2. Market Share and Forecast
      1. By Type
      2. By Technology
      3. By Application
      4. By End-User
      5. By Country
         1. China
         2. India
         3. Japan
         4. South Korea
         5. Rest of APAC
9. LATAM Wearable Injectors Market Overview
   1. Market Technology and Forecast
      1. By Value (USD Billion), 2020-2027
   2. Market Share and Forecast
      1. By Type
      2. By Technology
      3. By Application
      4. By End-User
      5. By Country
         1. Mexico
         2. Brazil
         3. Rest of LATAM
10. MEA Wearable Injectors Market Overview
    1. Market Technology and Forecast
       1. By Value (USD Billion), 2020-2027
    2. Market Share and Forecast
    3. By Type
    4. By Technology
    5. By Application
    6. By End-User
    7. By Country
       1. Saudi Arabia
       2. UAE
       3. South Africa
       4. Rest of MEA
11. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Market Share Analysis (2020)
    3. Competitive Benchmarking by Operating Parameters
12. Impact of COVID-19 on Global Wearable Injectors Market
13. Company Profiles (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *
    1. Amgen Inc.
    2. Ypsomed
    3. Becton, Dickinson and Company
    4. Tandem Diabetes Care, Inc.
    5. Dexcom, Inc.
    6. Sensile Medical
    7. Enable Injections
    8. Insulet Corporation
    9. Medtronic plc
    10. Johnson & Johnson
    11. F. Hoffmann-La Roche Ltd.
    12. Neuma
    13. Weibel CDS AG
    14. Sorrel Medical
    15. Stevanato Group
    16. Sonceboz
    17. Elcam Drug Delivery Devices
    18. West Pharmaceutical Services, Inc.
    19. Sensile Medical
    20. Other Prominent Players
14. Key Strategic Recommendations

List of Figures

Figure 1: Global Wearable Injectors Market Segmentation

Figure 2: Global Wearable Injectors Market Value Chain Analysis,

Figure 3: Company Market Share Analysis, 2020

Figure 4: Global Wearable Injectors Market Technology, By Value (USD Billion), 2017-2027

Figure 5: Global Wearable Injectors Market Share (%), By Type, By Value, 2017-2027

Figure 6: Global Wearable Injectors Market Share (%), By Technology, By Value, 2017-2027

Figure 7: Global Wearable Injectors Market Share (%), By Application, By Value, 2017-2027

Figure 8: Global Wearable Injectors Market Share (%), By End-User, By Value, 2017-2027

Figure 9: Global Wearable Injectors Market Share (%), By Region, By Value, 2017-2027

Figure 10: North America Wearable Injectors Market Technology, By Value (USD Billion), 2017-2027

Figure 11: North America Wearable Injectors Market Share (%), By Type, By Value, 2017-2027

Figure 12: North America Wearable Injectors Market Share (%), By Technology, By Value, 2017-2027

Figure 13: North America Wearable Injectors Market Share (%), By Application, By Value, 2017-2027

Figure 14: North America Wearable Injectors Market Share (%), By End-User, By Value, 2017-2027

Figure 15: North America Wearable Injectors Market Share (%), By Country, By Value, 2017-2027

Figure 16: Europe Wearable Injectors Market Technology, By Value (USD Billion), 2017-2027

Figure 17: Europe Wearable Injectors Market Share (%), By Type, By Value, 2017-2027

Figure 18: Europe Wearable Injectors Market Share (%), By Technology, By Value, 2017-2027

Figure 19: Europe Wearable Injectors Market Share (%), By Application, By Value, 2017-2027

Figure 20: Europe Wearable Injectors Market Share (%), by End-User, By Value, 2017-2027

Figure 21: Europe Wearable Injectors Market Share (%), By Country, By Value, 2017-2027

Figure 22: Asia-Pacific Wearable Injectors Market Technology, By Value (USD Billion), 2017-2027

Figure 23: Asia-Pacific Wearable Injectors Market Share (%), By Type, By Value, 2017-2027

Figure 24: Asia-Pacific Wearable Injectors Market Share (%), By Technology, By Value, 2017-2027

Figure 25: Asia-Pacific Wearable Injectors Market Share (%), By Application, By Value, 2017-2027

Figure 26: Asia-Pacific Wearable Injectors Market Share (%), By End-User, By Value, 2017-2027

Figure 27: Asia-Pacific Wearable Injectors Market Share (%), By Country, By Value, 2017-2027

Figure 28: Latin America Wearable Injectors Market Technology, By Value (USD Billion), 2017-2027

Figure 29: Latin America Wearable Injectors Market Share (%), By Type, By Value, 2017-2027

Figure 30: Latin America Wearable Injectors Market Share (%), By Technology, By Value, 2017-2027

Figure 31: Latin America Wearable Injectors Market Share (%), By Application, By Value, 2017-2027

Figure 32: Latin America Wearable Injectors Market Share (%), By End-User, By Value, 2017-2027

Figure 33: Latin America Wearable Injectors Market Share (%), By Country, By Value, 2017-2027

Figure 34: Middle East & Africa Wearable Injectors Market Technology, By Value (USD Billion), 2017-2027

Figure 35: Middle East & Africa Wearable Injectors Market Share (%), By Type, By Value, 2017-2027

Figure 36: Middle East & Africa Wearable Injectors Market Share (%), By Technology, By Value, 2017-2027

Figure 37: Middle East & Africa Wearable Injectors Market Share (%), By Application, By Value, 2017-2027

Figure 38: Middle East & Africa Wearable Injectors Market Share (%), By End-User, By Value, 2017-2027

Figure 39: Middle East & Africa Wearable Injectors Market Share (%), By Region, By Value, 2017-2027

List of Tables

Table 1: Global Wearable Injectors Market Technology, By Type, By Value, 2017-2027

Table 2: Global Wearable Injectors Market Technology, By Technology, By Value (USD Billion), 2017-2027

Table 3: Global Wearable Injectors Market Technology, By Application, By Value (USD Billion), 2017-2027

Table 4: Global Wearable Injectors Market Technology, By End-User, By Value (USD Billion), 2017-2027

Table 5: Global Wearable Injectors Market Technology, By Region, By Value (USD Billion), 2017-2027

Table 6: North America Wearable Injectors Market Technology, By Type, By Value (USD Billion), 2017-2027

Table 7: North America Wearable Injectors Market Technology, By Technology, By Value (USD Billion), 2017-2027

Table 8: North America Wearable Injectors Market Technology, By Application, By Value (USD Billion), 2017-2027

Table 9: North America Wearable Injectors Market Technology, By End-User, By Value (USD Billion), 2017-2027,

Table 10: Europe Wearable Injectors Market Technology, By Type, By Value (USD Billion), 2017-2027

Table 11: Europe Wearable Injectors Market Technology, By Technology, By Value (USD Billion), 2017-2027

Table 12: Europe Wearable Injectors Market Technology, By Application, By Value (USD Billion), 2017-2027

Table 13: Europe Wearable Injectors Market Technology, By End-User, By Value (USD Billion), 2017-2027

Table 14: the Asia-Pacific Wearable Injectors Market Technology, By Type, By Value (USD Billion), 2017-2027

Table 15: the Asia-Pacific Wearable Injectors Market Technology, By Technology, By Value (USD Billion), 2017-2027

Table 16: the Asia-Pacific Wearable Injectors Market Technology, By Application, By Value (USD Billion), 2017-2027

Table 17: the Asia-Pacific Wearable Injectors Market Technology, By End-User, By Value (USD Billion), 2017-2027

Table 18: Latin America Wearable Injectors Market Technology, By Type, By Value (USD Billion), 2017-2027

Table 19: Latin America Wearable Injectors Market Technology, By Technology, By Value (USD Billion), 2017-2027

Table 20: Latin America Wearable Injectors Market Technology, By Application, By Value (USD Billion), 2017-2027

Table 21: Latin America Wearable Injectors Market Technology, By End-User, By Value (USD Billion), 2017-2027

Table 22: The Middle-East & Africa Wearable Injectors Market Technology, By Type, By Value (USD Billion), 2017-2027

Table 23: The Middle-East & Africa Wearable Injectors Market Technology, By Technology, By Value (USD Billion), 2017-2027

Table 24: The Middle-East & Africa Wearable Injectors Market Technology, By Application, By Value (USD Billion), 2017-2027

Table 25: The Middle-East & Africa Wearable Injectors Market Technology, By End-User, By Value (USD Billion), 2017-2027

Table 26: Amgen Inc. Financial Analysis

Table 27: Amgen Inc. Business Overview

Table 28: Ypsomed Financial Analysis

Table 29: Ypsomed Business Overview

Table 30: Becton, Dickinson and Company Corporation Financial Analysis

Table 31: Becton, Dickinson and Company Corporation Business Overview

Table 32: Tandem Diabetes Care, Inc. Financial Analysis

Table 33: Tandem Diabetes Care, Inc. Business Overview

Table 34: Dexcom, Inc. Financial Analysis

Table 35: Dexcom, Inc. Business Overview

Table 36: Sensile Medical Financial Analysis

Table 37: Sensile Medical Business Overview

Table 38: Enable Injections Financial Analysis

Table 39: Enable Injections Business Overview

Table 40: Insulet Corporation Financial Analysis

Table 41: Insulet Corporation Business Overview

Table 42: Medtronic plc Financial Analysis

Table 43: Medtronic plc Business Overview

Table 44: Johnson & Johnson Financial Analysis

Table 45: Johnson & Johnson Business Overview

Table 46: F. Hoffmann-La Roche Ltd. Financial Analysis

Table 47: F. Hoffmann-La Roche Ltd. Financial Analysis

Table 48: Neuma Financial Analysis

Table 49: Neuma Business Overview

Table 50: Weibel CDS AG Financial Analysis

Table 51: Weibel CDS AG Business Overview

Table 52: Sorrel Medical Financial Analysis

Table 53: Sorrel Medical Business Overview

Table 54: Stevanato Group Financial Analysis

Table 55: Stevanato Group Business Overview

Table 56: Sonceboz Financial Analysis

Table 57: Sonceboz Business Overview

Table 58: Elcam Drug Delivery Devices Financial Analysis

Table 59: Elcam Drug Delivery Devices Business Overview

Table 60: West Pharmaceutical Services, Inc. Financial Analysis

Table 61: West Pharmaceutical Services, Inc. Business Overview

Table 62: Sensile Medical Financial Analysis

Table 63: Sensile Medical Business Overview